Medical devices: US medical device regulation

Area of Science:

• Medical Device Regulation
• Public Health Policy
• Regulatory Science

Background:

• The US Food and Drug Administration (FDA) Center for Devices and Radiological Health oversees medical device safety, effectiveness, and quality.
• FDA's regulatory authority for medical devices was established in 1976.
• Device regulation focuses on ensuring product safety throughout the total product life cycle.

Purpose of the Study:

• To outline the regulatory framework for medical devices in the United States.
• To describe the different pathways for medical device approval and clearance.
• To explain the FDA's role in ensuring the safety and efficacy of medical devices.

Main Methods:

• Classification of medical devices based on complexity and risk.
• Description of regulatory pathways: 510(k) premarket notification, Premarket Approval (PMA), and de novo classification.
• Explanation of Investigational Device Exemptions (IDE) for clinical investigations.

Main Results:

• Pre-1976 devices were grandfathered without FDA review.
• Post-1976 lower-risk devices can be cleared via 510(k) if substantially equivalent to a predicate, often without clinical data.
• Higher-risk devices require Premarket Approval (PMA) with robust safety and efficacy data, typically including clinical data.

Conclusions:

• The FDA employs a risk-based approach to medical device regulation.
• Regulatory pathways are tailored to device risk, with higher-risk devices undergoing more rigorous review.
• The de novo process provides a pathway for novel low-to-moderate risk devices, and IDEs facilitate clinical research.